Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 37451-37500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06270381
Empower-Grief: A Study on a Selective Intervention to Prevent Prolonged Grief Disorder
NARecruiting
44 participants
Started: Aug 7, 2023 · Completed: Nov 1, 2024
1 condition1 sponsor1 location
NCT05453396
Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies
PHASE2Recruiting
40 participants
Started: Aug 7, 2023 · Completed: Jul 6, 2027
11 conditions1 sponsor1 location
NCT05956756
Resilience Programming for Occupational Therapy Students
NARecruiting
130 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06125860
BEP Targeting Strategies in Ethiopia
NARecruiting
6,750 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2025
8 conditions3 sponsors1 location
NCT05896137
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
PHASE2Recruiting
50 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor12 locations
NCT05809258
Supraclavicular Versus Axillary Block for Arteriovenous (AV) Fistula Creation
NARecruiting
120 participants
Started: Aug 7, 2023 · Completed: May 31, 2025
3 conditions1 sponsor1 location
NCT05992077
Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia
NARecruiting
21,000 participants
Started: Aug 7, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor4 locations
NCT05856890
HepB mAb19 in Individuals With Chronic Hepatitis B Infection
PHASE1Recruiting
37 participants
Started: Aug 7, 2023 · Completed: Mar 30, 2028
2 conditions2 sponsors2 locations
NCT05956860
Radial Access for Abdominopelvic Vascular Intervention
N/ARecruiting
1,143 participants
Started: Aug 7, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05879224
Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia
NARecruiting
11,250 participants
Started: Aug 7, 2023 · Completed: Jul 31, 2025
2 conditions13 sponsors6 locations
NCT05970016
A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.
PHASE1/PHASE2Recruiting
56 participants
Started: Aug 7, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06863727
The Beijing Longitudinal Disability Survey in Community Elderly
N/ARecruiting
1,962 participants
Started: Aug 7, 2023 · Completed: Jul 31, 2028
5 conditions2 sponsors1 location
NCT06013189
Re-Adjustment of Sweep Gas Flow to the During the Rewarming Period of the Cardiopulmonary Bypass
N/ARecruiting
90 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2034
2 conditions1 sponsor1 location
NCT05834491
A Novel Approach to Plantar Fasciitis in the Aging Population
PHASE2Recruiting
138 participants
Started: Aug 7, 2023 · Completed: May 31, 2025
1 condition3 sponsors1 location
NCT05874271
Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
NARecruiting
900 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2025
2 conditions8 sponsors4 locations
NCT05981183
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
NARecruiting
20 participants
Started: Aug 7, 2023 · Completed: Jan 7, 2026
1 condition1 sponsor1 location
NCT05876312
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
PHASE1/PHASE2Recruiting
50 participants
Started: Aug 7, 2023 · Completed: Sep 30, 2026
1 condition3 sponsors4 locations
NCT05594238
Leveraging Virtual Care Strategies to Improve Access and Treatment for Individuals With Alcohol Use Disorders
NARecruiting
400 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT05992298
Feasibility Testing of 7-Tesla Magnetic Resonance Imaging
NARecruiting
780 participants
Started: Aug 7, 2023 · Completed: Feb 29, 2028
1 condition1 sponsor1 location
NCT05993832
Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
NARecruiting
40 participants
Started: Aug 7, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06329765
CUped: An Approach to Motor Recovery Post-Stroke, Not Compensation
NARecruiting
12 participants
Started: Aug 7, 2023 · Completed: Apr 4, 2027
2 conditions2 sponsors1 location
NCT06001151
Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCLC) Patients With Programmed Cell Death Ligand 1 (PD-L1) Negative
PHASE2Recruiting
49 participants
Started: Aug 7, 2023 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT05939739
Study of the Value of Trio Exome Sequencing in the Etiological Assessment of Specific Non-syndromic Language and Learning Disorders
NARecruiting
101 participants
Started: Aug 7, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05553041
18F-Fluciclovine PET-MRI in High-grade Glioma
EARLY_PHASE1Recruiting
30 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2026
5 conditions3 sponsors1 location
NCT05851391
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
PHASE2Recruiting
30 participants
Started: Aug 7, 2023 · Completed: Apr 30, 2027
7 conditions2 sponsors1 location
NCT06049667
A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
PHASE1Recruiting
72 participants
Started: Aug 7, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06033781
Cognitive-Behavioral Therapy for Children With Nightmares
NARecruiting
90 participants
Started: Aug 7, 2023 · Completed: Jan 1, 2026
3 conditions2 sponsors2 locations
NCT06543290
Azithromycin Before Induction
PHASE1Recruiting
400 participants
Started: Aug 7, 2023 · Completed: Aug 7, 2026
1 condition1 sponsor1 location
NCT05024175
Long-term Follow-up of Subjects Treated With CAR T Cells
N/ARecruiting
45 participants
Started: Aug 7, 2023 · Completed: Aug 1, 2039
7 conditions1 sponsor1 location
NCT05139589
The ENDOCARDITIS AUMC Data Collection
N/ARecruiting
3,000 participants
Started: Aug 6, 2023 · Completed: Dec 31, 2030
3 conditions1 sponsor1 location
NCT06572501
Robot-assisted Laparoscopic Partial Nephrectomy Via the Extraperitoneal Approach in the Prone Position Versus the Lateral Position
NARecruiting
200 participants
Started: Aug 6, 2023 · Completed: Jan 31, 2030
3 conditions1 sponsor1 location
NCT06835426
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
NARecruiting
150 participants
Started: Aug 6, 2023 · Completed: Jun 30, 2027
13 conditions1 sponsor1 location
NCT05542485
PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study
N/ARecruiting
97 participants
Started: Aug 6, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor3 locations
NCT06044285
Ultra Crave: An Investigation of Ultra-Processed Food
NARecruiting
210 participants
Started: Aug 5, 2023 · Completed: Aug 5, 2028
1 condition6 sponsors1 location
NCT05979233
One Session Vs Staged Management of Calcular Obstructive Jaundice
NARecruiting
110 participants
Started: Aug 5, 2023 · Completed: Feb 20, 2024
2 conditions1 sponsor1 location
NCT05894772
Evaluating a Virtual Stepped Care Portal in Youth Awaiting Tertiary Chronic Pain Care: An Implementation-Effectiveness Hybrid Type III Study
NARecruiting
93 participants
Started: Aug 5, 2023 · Completed: Sep 1, 2025
1 condition17 sponsors11 locations
NCT05957757
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression
PHASE2Recruiting
20 participants
Started: Aug 5, 2023 · Completed: Jun 8, 2026
2 conditions3 sponsors1 location
NCT06029036
A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer
PHASE2Recruiting
53 participants
Started: Aug 5, 2023 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT05989282
Structural Conditions and Health After Release From Prison
N/ARecruiting
400 participants
Started: Aug 5, 2023 · Completed: Jun 30, 2028
2 conditions4 sponsors1 location
NCT05841095
Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
PHASE1/PHASE2Recruiting
24 participants
Started: Aug 4, 2023 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT05243836
S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children
NARecruiting
441 participants
Started: Aug 4, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors8 locations
NCT05968677
Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients
NARecruiting
60 participants
Started: Aug 4, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05698732
Coroflex® ISAR NEO PMCF Study
N/ARecruiting
3,000 participants
Started: Aug 4, 2023 · Completed: Feb 1, 2027
2 conditions1 sponsor12 locations
NCT05994170
Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma
NARecruiting
454 participants
Started: Aug 4, 2023 · Completed: Sep 1, 2029
2 conditions2 sponsors1 location
NCT06004063
Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Paranteral Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Randomized Controlled Study
NARecruiting
40 participants
Started: Aug 4, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05553938
Effects of Acute and Chronic Empagliflozin Heart Failure
PHASE1Recruiting
60 participants
Started: Aug 4, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor2 locations
NCT06413212
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
N/ARecruiting
55 participants
Started: Aug 4, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05986643
Brain Training to Improve Balance in Parkinson's Disease
NARecruiting
100 participants
Started: Aug 4, 2023 · Completed: Jun 30, 2026
1 condition5 sponsors1 location
NCT05967585
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
NARecruiting
500 participants
Started: Aug 4, 2023 · Completed: Apr 5, 2027
2 conditions1 sponsor1 location
NCT05770531
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
PHASE2Recruiting
160 participants
Started: Aug 4, 2023 · Completed: Oct 1, 2028
2 conditions2 sponsors1 location